1U21
transthyretin with tethered inhibitor on one monomer.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL9-2 |
Synchrotron site | SSRL |
Beamline | BL9-2 |
Temperature [K] | 93 |
Detector technology | CCD |
Collection date | 2004-04-20 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.072 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 43.654, 85.643, 63.925 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 27.630 - 1.690 |
R-factor | 0.21783 |
Rwork | 0.217 |
R-free | 0.23865 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1bzd |
RMSD bond length | 0.015 |
RMSD bond angle | 1.552 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | CNS |
Refinement software | REFMAC (5.1.24) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 27.630 | 1.760 |
High resolution limit [Å] | 1.690 | 1.690 |
Number of reflections | 26531 | |
<I/σ(I)> | 33.2 | 2.3 |
Completeness [%] | 96.5 | 88.5 |
Redundancy | 3.4 | 2.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | PEG 4000, calcium chloride, VAPOR DIFFUSION, SITTING DROP, temperature 298K |